Apr 18, 04:20 PM

Canaan Partners Hires Ex-Pfizer Exec, Raises $1B, Secures $100M for Biotech

Canaan Partners, a longstanding venture capital firm, has recently bolstered its biotech investment portfolio by hiring former Pfizer executive Uwe Schoenbeck, Ph.D., who previously guided a Pfizer initiative to foster academic innovation, and securing an additional $100 million in funding. This new capital will be strategically deployed by Canaan's biopharma team, with a focus on startup formation and syndication efforts. The firm has successfully raised over $1 billion since early 2023, indicating a strong momentum in its investment activities.

#Canaan Partners #Pfizer #Uwe Schoenbeck #Canaan

Written with ChatGPT (GPT-4).

Sources

Economic Times@EconomicTimes
2 years ago
#HCG founder floats $20 million #healthcare and #LifeSciences #fund https://t.co/sZAoXb6VPa
STAT@statnews
2 years ago
Exclusive: A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 million in funding. https://t.co/88eefXzmAO
BioCentury@BioCentury
2 years ago
After years guiding a @Pfizer initiative to foster academic innovation, Uwe Schoenbeck has joined Canaan and led his first deal with the VC firm $PFE @pfizer_news @canaanpartners https://t.co/mIhbr1dMMc

Canaan Partners Hires Ex-Pfizer Exec, Raises $1B, Secures $100M for Biotech

Sources

Additional media

Similar Stories